Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 12-2018 | |
| Operating Expenses | 12,232 | 0 |
| Operating Income | -12,232 | N/A |
| Interest Expense | 11 | 0 |
| Other Income | 1,578 | 0 |
| Pre-tax Income | -10,665 | 0 |
| Net Income Continuous | -10,665 | N/A |
| Net Income | $-10,665 | $N/A |
| EPS Basic Total Ops | -2.90 | N/A |
| EPS Basic Continuous Ops | -2.90 | N/A |
| EPS Diluted Total Ops | -2.90 | N/A |
| EPS Diluted Continuous Ops | -2.90 | N/A |
| EBITDA(a) | $-12,232 | $N/A |